Overview
This course provides 35+ hours of CE/CME across 13 self-paced modules of comprehensive diabetes education for clinicians and diabetes care professionals — spanning everything from foundational pathophysiology to advanced pharmacotherapy, diabetes technology, complications management, inpatient care, and special populations.
More than a BC-ADM certification exam preparation pathway, this training program is built to prepare you for real-world practice: case-based simulations and clinical scenarios tie the content directly to the complex, multifactorial situations you’ll encounter in everyday diabetes care.
Aligned with national diabetes fellowship standards, the American Diabetes Association (ADA) Standards of Care in Diabetes, and American Association of Clinical Endocrinology (AACE) guidelines, the course streamlines exam preparation for those pursuing BC-ADM certification.
Beyond direct patient-care content, the course also covers the business and systems side of diabetes care — including clinic operations, population health, quality improvement frameworks, and regulatory and accreditation requirements — plus a dedicated module of additional topics tested on the BC-ADM exam.
We are pleased to share that this BC-ADM prep course is a CBDCE-Recognized Preparation Pathway. It has been reviewed by the Certification Board for Diabetes Care and Education (CBDCE) and determined to meet established preparation criteria for candidates pursuing BC-ADM certification. Participation is voluntary and does not guarantee certification or examination success.
Enrollment includes:
- 13 self-paced modules with 35+ hours of CE/CME-accredited recordings
- A 290+ question BC-ADM practice exam
- Live expert-led webinars with interactive Q&A, held at least quarterly
- Case-based simulations and real-world clinical scenarios that tie the content to practice
- One full year of access to all course content
Continuing education credits are available for physicians, nurses, pharmacists, physician associates, and dietitians. Click on the following to learn more:
Certification Period: July 15, 2026 – July 14, 2028
In support of improving patient care, this activity has been planned and implemented by the University of Iowa Roy J. and Lucille A. Carver College of Medicine and Diabetes Care Academy. The University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Dietitians: Completion of RD/DTR profession-specific or IPCE activity awards CPEUs (1 IPCE credits = 1 CPEU).
If the activity is dietetics related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (1 hour/60 minutes = 1 CPEU).
RDs and DTRs are to select activity type 102 in their Activity Logs.
Nurses: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 36.25 ANCC contact hours.
Pharmacists: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 36.25 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. UAN: JA0000310-9999-26-050-H01-P
Physician Associates: The University of Iowa Roy J. and Lucille A. Carver College of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 36.25 AAPA Category 1 CME credits. Approval is valid until July 14, 2028. PAs should only claim credit commensurate with the extent of their participation.
Physicians: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 36.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Natalie J. Bellini Speakers Bureau: Abbott Laboratories; Medtronic; Sanofi-Aventis | Membership on Advisory Committees or Review Panels, Board Membership, etc.: Sequel | Advisor: Medtronic
Julia Blanchette Advisor: Eli Lilly and Company; MannKind | Consulting Fee: Sequel MedTech; Embecta | Speakers Bureau: Insulet Corporation
Elena A. Christofides Speakers Bureau: Abbott Laboratories; Bayer Corporation; Eli Lilly and Company | Grant or Research Support: Eli Lilly and Company; Novo Nordisk
Susan Guzman Consulting Fee: Abbott Diabetes; Emabecta
Diana Isaacs Speakers Bureau: Dexcom; Insulet; Lilly; Novo Nordisk; Abbott Laboratories; Cequr; Beta Bionics; Sanofi; Sequel Medtech; Mannkind | Consulting Fee: Medtronic; Corcept
Janice MacLeod Consulting Fee: Beta Bionics; Welldoc; Trividia Health
Lucia Novak Honoraria: Abbott Diabetes Care; Novo Nordisk; Sanofi-US; Ascencia | Family Stock: Boehringer Ingelheim – Obesity
Katelyn O’Brien Advisor: Sanofi-Aventis; Eli Lilly; Insulet | Speakers Bureau: Cequr; Insulet
Brian O’Neill Family Stock:Amersham/GE Healthcare; Bristol Myers Squibb; Johnson & Johnson; Zimmer-Biomet; Pfizer
Rachel Salzman Consulting Fee: Medtronic, Inc.; Dexcom | Advisor: Undermyfork
Rifka C. Schulman-Rosenbaum Royalties or Patent Beneficiary: Sanofi-Aventis; Eli Lilly | Grant or Research Support: Sanofi-Aventis; Eli Lilly
Christine A. Schumacher Speakers Bureau: Abbott Laboratories
Devin W. Steenkamp Grant or Research Support: Abbott Laboratories; Tandem Diabetes Care; Novo Nordisk; MannKind; Insulet; DEKA Sequel Med Tech | Membership on Advisory Committees or Review Panels, Board Membership, etc.: Abbott Laboratories
Other course planners, reviewers, and faculty disclosed no relevant financial relationships.
All relevant financial relationships were mitigated.
